Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

331.93
BATS BZX Real-Time Price
As of 3:44pm ET
 +3.06 / +0.93%
Today’s Change
201.91
Today|||52-Week Range
340.34
+28.95%
Year-to-Date

Today’s Trading

Previous close328.87
Today’s open328.50
Day’s range326.29 - 332.00
Volume2,379,504
Average volume (3 months)2,152,244
Market cap$129.1B
Dividend yield--
Data as of 3:29pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+27.59%
Earnings growth (next 5 years)+15.30%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.35+0.65%
NVONovo Nordisk+0.63+1.08%
ABBVAbbVie-0.15-0.21%
BMYBristol-Myers Squibb+1.21+1.88%
Data as of 3:44pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$4.38
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts